Article
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
The American journal of surgical pathology - 1 Jun 2018
Chiang Sarah, Cotzia Paolo, Hyman David M, Drilon Alexander, Tap William D, Zhang Lei, Hechtman Jaclyn F, Frosina Denise, Jungbluth Achim A, Murali Rajmohan, Park Kay J, Soslow Robert A, Oliva Esther, Iafrate A John, Benayed Ryma, Ladanyi Marc, Antonescu Cristina R
Abstract excerpt
Tropomyosin receptor kinase (Trk) inhibitors have shown high response rates in patients with tumors harboring NTRK fusions. We identified 4 NTRK fusion-positive uterine sarcomas that should be distinguished from leiomyosarcoma and undifferentiated uterine sarcoma. NTRK rearrangements were detected by fluorescence in situ hybridization (FISH) and/or targeted RNA or DNA sequencing in 4 undifferentiated uterine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
